Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cytonectin expression in Alzheimer disease.

Soni J Anderson1, Peter E Barker, M Gary Hadfield

  • 1Department of Pathology, Virginia Commonwealth University, Medical College of Virginia Campus, Richmond 23298, USA.

Journal of Neuropathology and Experimental Neurology
|March 16, 2002
PubMed
Summary

Cytonectin, a novel adherence protein, is crucial for tissue structure and preventing immune attacks. It's overexpressed in Alzheimer disease, Down syndrome, and leukemia, suggesting a role in these conditions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biomarker Validation for Aging: Lessons from mtDNA Heteroplasmy Analyses in Early Cancer Detection.

Biomarker insights·2009
Same author

Quantitative infrared spectroscopy of formalin-fixed, paraffin-embedded tissue specimens: paraffin wax removal with organic solvents.

Applied immunohistochemistry & molecular morphology : AIMM·2009
Same author

Performance of mitochondrial DNA mutations detecting early stage cancer.

BMC cancer·2008
Same author

Quantitation of HER2 and telomerase biomarkers in solid tumors with IgY antibodies and nanocrystal detection.

International journal of cancer·2008
Same author

Validation of novel optical imaging technologies: the pathologists' view.

Journal of biomedical optics·2007
Same author

Inhibition of sulfur mustard-induced cytotoxicity and inflammation by the macrolide antibiotic roxithromycin in human respiratory epithelial cells.

BMC cell biology·2007

Area of Science:

  • Biochemistry
  • Cell Biology
  • Molecular Biology

Background:

  • Cytonectin is a novel 35,000 molecular weight protein with ion-independent adherence properties.
  • It belongs to a family of adherence molecules vital for cell communication and 3D tissue development.
  • Cytonectin is evolutionarily conserved across species and found in various organs and tissues.

Purpose of the Study:

  • To describe the properties of cytonectin.
  • To investigate the proposed role of cytonectin in normal and disease states.
  • To explore the potential significance of cytonectin in the etiopathogenesis of Alzheimer disease, Down syndrome, and leukemia.

Main Methods:

  • Characterization of cytonectin's adherence properties.
  • Analysis of cytonectin expression in various tissues.

Related Experiment Videos

  • Comparative analysis of cytonectin levels in Alzheimer disease patients versus age-matched controls.
  • Detection of cytonectin in tissues from patients with Down syndrome and leukemia.

    • Main Results:

    • Cytonectin exhibits remarkable ion-independent adherence.
    • It is expressed in diverse organs and tissues, conserved from humans to avians.
    • Cytonectin is overexpressed in the entorhinal cortex of Alzheimer disease patients compared to controls.
    • Cytonectin is detected in tissues associated with Down syndrome and leukemia.

    Conclusions:

    • Cytonectin is a key structural protein and a "do not attack" signal molecule.
    • Its overexpression in Alzheimer disease, Down syndrome, and leukemia suggests a significant role in their pathogenesis.
    • Further research into cytonectin's function may elucidate its importance in these disease states.